A critical advance in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This vital tumor suppressor protein is frequently disabled in various types of tumors, resulting uncontrolled https://wise-social.com/story7531510/vhh-fragments-restore-the-p53-protein-the-potential-pathway-for-malignant-treatment